| 晚期非小细胞肺癌维持治疗的研究进展 |
| |
| 引用本文： | 周倩,谭榜宪.晚期非小细胞肺癌维持治疗的研究进展[J].中国肿瘤临床,2021,48(12):631-635. |
| |
| 作者姓名： | 周倩 谭榜宪 |
| |
| 作者单位： | 1.川北医学院附属医院肿瘤科 （南充市637000） |
| |
| 摘 要： | 肺癌是全球发病率及死亡率最高的恶性肿瘤，虽然含铂双药化疗一定程度上提高了晚期非小细胞肺癌（non-small cell lung cancer，NSCLC）的疗效，但预后仍欠佳。为了进一步改善患者的生存，进行有效的维持治疗至关重要。本文就晚期NSCLC维持治疗的研究现状进行综述，探讨维持治疗的临床意义及如何选择个体化治疗方案。
|
| 关 键 词： | 非小细胞肺癌 维持治疗 靶向治疗 免疫治疗 联合治疗 |
| 收稿时间： | 2020-11-13 |
Research progress of maintenance therapy in advanced non-small cell lung cancer |
| |
| Institution: | 1.Department of Oncology, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, China2.Department of Oncology, Chongqing University Three Gorges Hospital, Chongqing 404000, China |
| |
| Abstract: | Lung cancer is a malignant tumor associated with the highest morbidity and mortality worldwide. Although platinum-based doublet chemotherapy has moderately improved the efficacy in advanced non-small cell lung cancer (NSCLC), prognosis of patients with NSCLC remains poor. To further improve the survival of patients with NSCLC, effective maintenance therapy is essential. This study reviews the current status of advanced NSCLC maintenance therapy and discusses the clinical significance of maintenance therapy and the selection process of an individualized treatment plan. |
| |
| Keywords: | |
|
| 点击此处可从《中国肿瘤临床》浏览原始摘要信息 |
| 点击此处可从《中国肿瘤临床》下载免费的PDF全文 |
